Global orthopedic sales totaled $62 billion in 2024, an increase of 5% compared to 2023. Read our regularly updated analysis of the orthopedic market, including sales forecasts for all segments, company revenue and insight into key trends.
The Numbers
Stay up to date on the orthopedic market’s 3Q performance in 2025 as we update this post with company sales data and industry developments.
The company grew in the high single digits on a reported basis for the third quarter of 2025 and saw improved U.S. performance.
October 29, 2025
,
Julie A. Vetalice
Stay up to date on the orthopedic market’s 3Q performance in 2025 as we update this post with company sales data and industry developments.
November 6, 2025
,
The company grew in the high single digits on a reported basis for the third quarter of 2025 and saw improved U.S. performance.
November 6, 2025
,
The company grew 30% in the third quarter of 2025 as it continues to take share from all major competitors in spine.
November 6, 2025
,
Excluding its divested spinal implant business, Stryker’s orthopedic sales grew in the double digits for the third quarter of 2025.
October 31, 2025
,
Customed’s cloud-based platform generates patient-specific surgical tools and implants through AI and automation with 3D printing, creating more precise orthopedic surgeries.
October 29, 2025
,
We surveyed sales performance outside the United States over the past several years for select orthopedic companies.
October 27, 2025
,
This latest round of funding strengthens Catalyst’s balance sheet as the company advances its commercial and clinical programs.
October 23, 2025
,
An overview of what is shaping the spine market, its leading players, geographic trends and our forecast for the next few years.
October 22, 2025
,
What went wrong for orthopedics at J&J MedTech and what might the future hold for the standalone DePuy Synthes?
October 17, 2025
,
Along with its third quarter earnings, J&J MedTech announced its intent to separate its orthopedics business into a standalone company.
October 15, 2025
,
The number of orthopedic investments continues to fall, but the total dollar amount available to companies has actually grown since 2020.
October 14, 2025
,
RevBio receives a $2.2 million phase II NIH grant to further develop the minimally invasive use of TETRANITE to treat complex spine fractures.
October 6, 2025
,
Five things we’re watching as the orthopedic market’s competitive landscape evolves and we move into the second half of 2025.
September 29, 2025
,
This new funding will fuel Spineart’s next phase of profitable growth, enabling the company to advance its innovation pipeline and strengthen its global footprint.
September 26, 2025
,
Our chart of the month tracks spine M&A activity over the last decade, including the seven deals done so far in 2025.
